ANTB
DFTX

AMG National Trust Bank’s Definium Therapeutics DFTX Stock Holding History

AMG National Trust Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+6,369
New +$157K 0.01% 389

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AMG National Trust Bank's DFTX Position: Q2 2026 in Review

AMG National Trust Bank opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 6,369 shares worth $300K. The stake represents 0.01% of the portfolio and ranks #389 among its holdings.

129 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • AMG National Trust Bank held 6,369 shares of Definium Therapeutics worth $300K as of Q2 2026.
  • Definium Therapeutics was a new AMG National Trust Bank position in Q2 2026.
  • Definium Therapeutics made up 0.01% of AMG National Trust Bank's portfolio in Q2 2026, its #389 holding.
  • 129 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.